South Plainfield, NJ., March 12, 2020 — J-Star Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://www.jstar-research.com. The new site features a streamlined, modern design, improved functionality, and easy access to essential information to help […]
J-Star Research, Inc launches new website Read More »
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the basis of sincere cooperation and mutual benefit. As a high standard CDMO, Porton has outstanding integrated experiences in
Porton and Xtalpi Announced Strategic Cooperation Read More »
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the previously announced transcation with the shareholders of J-STAR Research, Inc. (“J-STAR”), a contract chemistry organization
Porton Completes Acquisition of J-STAR Research Read More »
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of J-STAR Research, Inc. (“J-STAR”), a contract chemistry organization based in South